Insmed
INSM
#752
Rank
S$39.99 B
Marketcap
S$182.32
Share price
-2.17%
Change (1 day)
-31.49%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: S$39.99 Billion

As of November 2026 Insmed has a market cap of S$39.99 Billion. This makes Insmed the world's 752th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026S$39.99 B-17.88%
2025S$48.70 B187.74%
2024S$16.92 B189.1%
2023S$5.85 B61.36%
2022S$3.62 B-16.76%
2021S$4.35 B-2.83%
2020S$4.48 B55.38%
2019S$2.88 B108.37%
2018S$1.38 B-56.62%
2017S$3.19 B169.58%
2016S$1.18 B-25.34%
2015S$1.58 B55.88%
2014S$1.01 B20.77%
2013S$0.84 B227.23%
2012S$0.25 B162.63%
2011S$98.08 M-22.88%
2010S$0.12 B-9.63%
2009S$0.14 B72.12%
2008S$81.77 M-43.49%
2007S$0.14 B5.84%
2006S$0.13 B-37.34%
2005S$0.21 B35.49%
2004S$0.16 B-16.87%
2003S$0.19 B649.34%
2002S$25.85 M-88.9%
2001S$0.23 B18.1%
2000S$0.19 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Insmed was reported to be:

S$39.99 Billion
by Nasdaq info icon info icon
S$39.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
S$366.59 B 816.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$266.29 B 565.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$168.44 B 321.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.84 B-95.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.97 B-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$0.75 B-98.12%๐Ÿ‡บ๐Ÿ‡ธ USA